Reporter uses an AI digital twin to guide daily nutrition

By Splitfeed EditorialLast updated Oct 14, 2026, 17:20 UTC

Victoria Song, a senior reviewer at The Verge, spent roughly 100 days using an AI-powered digital twin designed to guide her daily nutrition. Each morning, the system received body composition measurements from a smart scale as its first data input, then used that metabolic information to inform what Song ate throughout the day. Song writes about the experience in Optimizer, her weekly newsletter covering health and lifestyle technology.

The story sits at an intersection of several active debates: the growing consumer market for personalized health AI, the question of whether body composition metrics are reliable enough to drive dietary decisions, and the broader issue of delegating consequential daily choices to automated systems. Unlike a passive fitness tracker, this setup involves the AI actively directing behavior, which raises the stakes around accuracy, bias in the underlying models, and what happens when the system gets things wrong. No independent studies, clinical endorsements, or comparative outcome data appear in the available account, which leaves the core question, whether following the AI's guidance produced meaningful health benefits, unanswered.

With no published reactions yet from any camp, their likely positions can be sketched from the shape of the story. Pro-AI voices would typically highlight this as a promising example of personalized medicine becoming accessible to ordinary consumers, arguing that continuous metabolic feedback loops are exactly the kind of problem AI is well suited to solve. Anti-AI voices would typically raise concerns about the absence of clinical validation, the risks of nudging eating behavior based on potentially noisy scale data, and the commercial incentives of whoever built the system. Middle-ground observers would likely want to know whether Song's outcomes were measurably positive before drawing conclusions, and would caution against treating one journalist's self-experiment as evidence of broader efficacy.

The natural next development to watch is whether Song publishes outcome data, a follow-up assessment, or a named review of the specific product and company involved, any of which would give critics and supporters something concrete to evaluate.